相关实验视频
Updated: Jun 30, 2025

07:54
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
10.3K
在新生儿中,怀孕期的免疫性肝病与阿尔法血症
Nishant Banait1, Sai Vamshi Varanasi2, Abinash Nayak2
1Neonatology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India nishantbanait@aiimsnagpur.edu.in.
BMJ case reports
|March 21, 2024
概括
本案例研究突出了一个罕见的妊娠性非免疫性肝病-新生儿血红色变异症 (GALD-NH) 案例,该病例成功地用静脉注射免疫球蛋白 (IVIG) 治疗. 该报告详细介绍了一例来自印度的独特病例,该病例涉及同时发生的阿尔法血病.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 新生儿科学 新生儿科学
- 免疫学 免疫学 免疫学
背景情况:
- 妊娠性非免疫性肝病-新生儿血色变异 (GALD-NH) 是一种罕见且严重的疾病,导致新生儿肝衰竭.
- 从历史上看,GALD-NH的死亡率很高,往往需要进行肝移植.
- 最近在母体和新生儿静脉注射免疫球蛋白 (IVIG) 治疗方面的进展表明,改善治疗结果是有前途的.
研究的目的:
- 报告在新生儿中成功治疗GALD-NH的IVIG治疗.
- 为了记录印度首次报告的用IVIG治疗的GALD-NH病例.
- 为了突出在临床病例中GALD-NH和alpha thalassemia的同时发生.
主要方法:
- 一个患有胆固醇黄的新生儿的临床表现和诊断评估.
- 通过临床评估证实了GALD-NH的诊断.
- 基因检测以确认阿尔法血病.
- 治疗方法:静脉注射免疫球蛋白 (IVIG).
主要成果:
- 被诊断为GALD-NH的新生儿在IVIG治疗后逐渐恢复.
- 通过同一个患者的遗传检测确定并证实了阿尔法沙拉西米亚.
- 这一案例代表了印度次大陆GALD-NH在IVIG基础上的成功治疗.
结论:
- 静脉注射免疫球蛋白 (IVIG) 疗法可以有效治疗妊娠性非免疫性肝病-新生儿血红色变异 (GALD-NH).
- 这一案例强调了考虑和管理诸如阿尔法沙拉西米亚等并存疾病的重要性.
- 成功的IVIG治疗为GALD-NH提供了肝移植的有希望的替代方案,特别是在资源有限的地区.
相关概念视频
Development of Immunocompetence
306
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
306
Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Inborn Errors of Metabolism
157
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
157
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Bone Marrow Sampling and Transplants
328
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
328

